BIOMAT Database Logo BIOMAT Database Logo

[Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy]. 1977

N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin

Patients with malignant skin melanoma were given different kinds of immunotherapy; nonspecific immunotherapy with BCG vaccine, adaptive immunotherapy with methotrexate or phytohemagglutinin activated autolymphocytes, and also a combination of polychemotherapy with BCG. The state of cell immunity was determined prior to, during and at the end of the therapy, in accordance with the courses. As a result of the conducted therapy an increased level of cell immunity was observed, that usually corresponded to clinical development of the disease. At the same time, the increase in immune response indices due to continuous administration of BCG vaccine is not related with the clinical course, while the persistent anergy or reduced level of cell immunity during this kind of therapy is a poor prognostic sign.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions

Related Publications

N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin
[Adaptive reactions of patients with chronic nonspecific lung diseases].
September 1988, Vrachebnoe delo,
N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin
[Immunological status of laryngeal cancer patients and the problems of nonspecific immunotherapy].
January 1981, Vestnik otorinolaringologii,
N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin
[The reaction of the T-immunity system in patients with malignant skin melanoma and stomach cancer to active nonspecific immunotherapy].
January 1992, Voprosy onkologii,
N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin
[ON NONSPECIFIC IMMUNOLOGICAL REACTIONS THE NONSPECIFIC IMMUNOLOGICAL REACTIVITY OF THE BODY IN ANTIBIOTIC TREATMENT OF PATIENTS WITH PURULENT INFECTIONS].
December 1963, Problemy gematologii i perelivaniia krovi,
N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin
[Adaptive reactions and nonspecific resistance of the body in patients with scoliosis].
May 1983, Ortopediia travmatologiia i protezirovanie,
N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin
Introduction--immunological reactions and immunotherapy of malignant disease.
January 1979, Advances in experimental medicine and biology,
N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin
[Nonspecific adaptation reactions and immunological status in patients with type 2 diabetes mellitus].
March 2010, Klinicheskaia laboratornaia diagnostika,
N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin
[Nonspecific adaptive reactions blood in chronic brain ischemia].
December 2010, Klinicheskaia laboratornaia diagnostika,
N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin
Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma.
March 2023, Cancers,
N N Trapeznikov, and V V Iavorskiĭ, and Z G Kadagidze, and S G Malaev, and V I Kupin
[The nonspecific protective reactions and immunological reactivity of the body in peptic ulcer patients].
April 1992, Khirurgiia,
Copied contents to your clipboard!